Cisapride decreases gastric content aspiration in mechanically ventilated patients
Objective:
To determine the effect of the prokinetic agent cisapride in the
prevention of aspiration of gastric contents.
Design:
A prospective randomized two-period crossover study.
Setting:
Fourteen-bed polyvalent intensive care unit in a University
Hospital.
Patients:
Eighteen intubated, mechanically ventilated patients who were
seated in a semirecumbent position were studied.
Method:
Tc-99 m sulfur colloid (80 megabecquerels) was administered via
nasogastric tube on 2 consecutive days. Patients randomly received cisapride
(10 mg, via nasogastric tube) one day and a placebo the other. Bronchial
secretions were obtained before and for 5 consecutive h after Tc-99 m
administration. The radioactivity was measured in a standard amount (1ml) of
bronchial fluid using a gamma counter and expressed as counts per min (cpm)
after correction for decay.
Results:
Sixteen out of 18 (88%) patients had increased radioactivity in
bronchial secretions. The radioactivity increased over time both with and
without cisapride, although it was lower in patients receiving cisapride than
in those receiving a placebo. The cumulative bronchial secretion radioactivity
obtained when patients received cisapride was significantly lower than when
patients received a placebo: 7540 ± 5330 and 21965 ± 16080 cpm,
respectively (P <0.05).
Conclusion:
Our results suggest that aspiration of gastric contents exists
even in patients who are kept in a semirecumbent position. Moreover, cisapride
decreases the amount of gastric contents aspiration in intubated and
mechanically ventilated patients and may play a role in the prevention of
ventilator associated pneumonia. Cisapride, even with the patient in the
semirecumbent position, did not completely prevent gastric content
aspiration.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[
"009:25"
]
|
| contactPoint |
{
"fn": "NIH",
"@type": "vcard:Contact",
"hasEmail": "mailto:info@nih.gov"
}
|
| description | Objective: To determine the effect of the prokinetic agent cisapride in the prevention of aspiration of gastric contents. Design: A prospective randomized two-period crossover study. Setting: Fourteen-bed polyvalent intensive care unit in a University Hospital. Patients: Eighteen intubated, mechanically ventilated patients who were seated in a semirecumbent position were studied. Method: Tc-99 m sulfur colloid (80 megabecquerels) was administered via nasogastric tube on 2 consecutive days. Patients randomly received cisapride (10 mg, via nasogastric tube) one day and a placebo the other. Bronchial secretions were obtained before and for 5 consecutive h after Tc-99 m administration. The radioactivity was measured in a standard amount (1ml) of bronchial fluid using a gamma counter and expressed as counts per min (cpm) after correction for decay. Results: Sixteen out of 18 (88%) patients had increased radioactivity in bronchial secretions. The radioactivity increased over time both with and without cisapride, although it was lower in patients receiving cisapride than in those receiving a placebo. The cumulative bronchial secretion radioactivity obtained when patients received cisapride was significantly lower than when patients received a placebo: 7540 ± 5330 and 21965 ± 16080 cpm, respectively (P <0.05). Conclusion: Our results suggest that aspiration of gastric contents exists even in patients who are kept in a semirecumbent position. Moreover, cisapride decreases the amount of gastric contents aspiration in intubated and mechanically ventilated patients and may play a role in the prevention of ventilator associated pneumonia. Cisapride, even with the patient in the semirecumbent position, did not completely prevent gastric content aspiration. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Official Government Data Source",
"mediaType": "text/html",
"description": "Visit the original government dataset for complete information, documentation, and data access.",
"downloadURL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC29012/"
}
]
|
| identifier | https://healthdata.gov/api/views/v9jb-5h2i |
| issued | 2025-07-13 |
| keyword |
[
"aspiration-prevention",
"cisapride-treatment",
"gastric-content",
"mechanical-ventilation",
"nih"
]
|
| landingPage | https://healthdata.gov/d/v9jb-5h2i |
| modified | 2025-09-06 |
| programCode |
[
"009:032"
]
|
| publisher |
{
"name": "National Institutes of Health",
"@type": "org:Organization"
}
|
| theme |
[
"NIH"
]
|
| title | Cisapride decreases gastric content aspiration in mechanically ventilated patients |